Swissray enters Asian imaging market
Asia is the latest foreign healthcare market to embrace digital x-ray. Swissray International, which has sold its ddR-MultiSystem to hospitals in the U.S., South America, Western Europe, and Eastern Europe, now counts Kaohsiung Veterans General Hospital
Asia is the latest foreign healthcare market to embrace digital x-ray. Swissray International, which has sold its ddR-MultiSystem to hospitals in the U.S., South America, Western Europe, and Eastern Europe, now counts Kaohsiung Veterans General Hospital in Taiwan as a customer. Sales figures were not disclosed.
Taiwan would like to advance its radiological practices, said Dr. Yang Chien-Fang, Kaoshiung Veterans General Hospitals superintendent, in a written statement. Chien-Fang said he was impressed with the systems ability to store information and display Chinese characters on its console.
This is the first time Swissray has sold x-ray equipmentfilm or digitalto Taiwan. Taiwanese hospitals commonly use film systems, said Dr. Pan Huay-Ben, Kaohsiung Veterans General Hospitals director of radiology.
The U.S. medical community has been slower to accept digital x-ray than overseas medical communities.
For example, fewer than 100 digital radiography systems have been sold worldwide, and only about half of these have gone to sites in the U.S. Both Swissray and GE Medical Systems report rising DR sales, although many are to overseas customers.
In the last four years, Swissray has taken orders for 65 digital units. Of these, 32 will be delivered this spring to sites in Romania (SCAN 2/1/00). GE claims to have sold 23 Revolution XQ/I digital chest systems last year, with about half of these going to U.S. sites (SCAN 10/27/99).
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
